MCLAREN JEFFREY L 4

What Happened
Jeffrey L. McLaren, a director of HealthStream, was granted 3,654 restricted stock units (RSUs) on May 28, 2026. The grant is reported as an award/acquisition (derivative) at $0.00 per unit (total reported value $0), representing the contingent right to receive one share of common stock per RSU upon vesting. This was a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-28; Report filed: 2026-06-01 (filed within the typical 2-business-day Form 4 window).
• Grant: 3,654 RSUs reported at $0.00 per unit (derivative award, code A).
• Vesting: RSUs vest annually in three equal installments beginning May 28, 2027 (three-year service-contingent schedule).
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: F1 — each RSU converts to one share upon vesting; F2 — three-year annual vesting schedule; F3 — not applicable.

Context
RSU grants are a form of equity-based compensation and do not necessarily indicate buying or selling intent in the market. These units are contingent on continued service and will result in issuance of shares only as they vest (and may be subject to tax withholding at vesting). For retail investors, such awards signal routine executive/director compensation and potential future dilution if and when the RSUs convert to shares.